Cost-Effectiveness Analysis of Oxaliplatin Plus Fluorouracil/Leucovorin (Folfox4) Compared to Sorafenib for Treatment of Advanced Hepatocellular Carcinoma Patients in China
Nov 1, 2016, 00:00
10.1016/j.jval.2016.08.277
https://www.valueinhealthjournal.com/article/S1098-3015(16)30857-9/fulltext
Title :
Cost-Effectiveness Analysis of Oxaliplatin Plus Fluorouracil/Leucovorin (Folfox4) Compared to Sorafenib for Treatment of Advanced Hepatocellular Carcinoma Patients in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30857-9&doi=10.1016/j.jval.2016.08.277
First page :
A889
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2739